Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 767 | 1 | 0.1 | 203 | 26.5 | 154 | 20.1 | 301 | 39.2 | 108 | 14.1 |
2015-2019 | 787 | 2 | 0.3 | 200 | 25.4 | 169 | 21.5 | 309 | 39.3 | 107 | 13.6 |
2014-2018 | 758 | 1 | 0.1 | 185 | 24.4 | 149 | 19.7 | 318 | 42.0 | 105 | 13.9 |
2013-2017 | 756 | 2 | 0.3 | 174 | 23.0 | 147 | 19.4 | 329 | 43.5 | 104 | 13.8 |
2012-2016 | 772 | 2 | 0.3 | 188 | 24.4 | 159 | 20.6 | 345 | 44.7 | 78 | 10.1 |
2011-2015 | 789 | 3 | 0.4 | 190 | 24.1 | 156 | 19.8 | 375 | 47.5 | 65 | 8.2 |
2010-2014 | 786 | 2 | 0.3 | 187 | 23.8 | 149 | 19.0 | 385 | 49.0 | 63 | 8.0 |
2009-2013 | 775 | 2 | 0.3 | 178 | 23.0 | 154 | 19.9 | 384 | 49.5 | 57 | 7.4 |
2008-2012 | 760 | 3 | 0.4 | 166 | 21.8 | 138 | 18.2 | 386 | 50.8 | 67 | 8.8 |
2007-2011 | 777 | 3 | 0.4 | 148 | 19.0 | 141 | 18.1 | 407 | 52.4 | 78 | 10.0 |
2006-2010 | 792 | 2 | 0.3 | 148 | 18.7 | 155 | 19.6 | 396 | 50.0 | 91 | 11.5 |
2005-2009 | 813 | 2 | 0.2 | 144 | 17.7 | 158 | 19.4 | 418 | 51.4 | 91 | 11.2 |
2004-2008 | 828 | 3 | 0.4 | 145 | 17.5 | 160 | 19.3 | 429 | 51.8 | 91 | 11.0 |
2003-2007 | 784 | 3 | 0.4 | 137 | 17.5 | 171 | 21.8 | 385 | 49.1 | 88 | 11.2 |
2002-2006 | 725 | 3 | 0.4 | 131 | 18.1 | 166 | 22.9 | 333 | 45.9 | 92 | 12.7 |
2001-2005 | 700 | 4 | 0.6 | 125 | 17.9 | 174 | 24.9 | 310 | 44.3 | 87 | 12.4 |
2000-2004 | 659 | 5 | 0.8 | 137 | 20.8 | 162 | 24.6 | 253 | 38.4 | 102 | 15.5 |
1999-2003 | 615 | 5 | 0.8 | 144 | 23.4 | 158 | 25.7 | 200 | 32.5 | 108 | 17.6 |
1998-2002 | 617 | 5 | 0.8 | 176 | 28.5 | 141 | 22.9 | 195 | 31.6 | 100 | 16.2 |
1997-2001 | 635 | 5 | 0.8 | 205 | 32.3 | 126 | 19.8 | 203 | 32.0 | 96 | 15.1 |
1996-2000 | 640 | 4 | 0.6 | 237 | 37.0 | 103 | 16.1 | 191 | 29.8 | 105 | 16.4 |
1995-1999 | 674 | 3 | 0.4 | 265 | 39.3 | 104 | 15.4 | 179 | 26.6 | 123 | 18.2 |
1994-1998 | 661 | 2 | 0.3 | 255 | 38.6 | 96 | 14.5 | 175 | 26.5 | 133 | 20.1 |
1993-1997 | 659 | 3 | 0.5 | 249 | 37.8 | 94 | 14.3 | 167 | 25.3 | 146 | 22.2 |
1992-1996 | 647 | 3 | 0.5 | 247 | 38.2 | 99 | 15.3 | 149 | 23.0 | 149 | 23.0 |
1991-1995 | 639 | 4 | 0.6 | 241 | 37.7 | 98 | 15.3 | 141 | 22.1 | 155 | 24.3 |
1990-1994 | 616 | 5 | 0.8 | 229 | 37.2 | 107 | 17.4 | 139 | 22.6 | 136 | 22.1 |
1989-1993 | 624 | 5 | 0.8 | 235 | 37.7 | 117 | 18.8 | 136 | 21.8 | 131 | 21.0 |
1988-1992 | 596 | 3 | 0.5 | 224 | 37.6 | 120 | 20.1 | 124 | 20.8 | 125 | 21.0 |
1987-1991 | 572 | 3 | 0.5 | 210 | 36.7 | 118 | 20.6 | 128 | 22.4 | 113 | 19.8 |
1986-1990 | 529 | 2 | 0.4 | 183 | 34.6 | 125 | 23.6 | 120 | 22.7 | 99 | 18.7 |
1985-1989 | 477 | 1 | 0.2 | 156 | 32.7 | 107 | 22.4 | 119 | 24.9 | 94 | 19.7 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |